Windtree TherapeuticsWINT
13F holders, Q1 2025 (March 31)5holders
$1.26avg. 13F price*
At the end of Q1 2025, 5 institutions reported holding Windtree Therapeutics Inc. (WINT) in their 13F filings. The largest holders were UBS Group AG ($36K), Morgan Stanley ($19K) and Tower Research Capital LLC (TRC) ($2K).
- Company
- Windtree Therapeutics Inc.
- CUSIP
- 97382D600
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $57K |
| Exits | 0 | $0 |
Ownership 5 holders
| UBS Group AG | 0.00% | New | 28,765 | $36K |
| Morgan Stanley | 0.00% | New | 15,000 | $19K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 1,376 | $2K |
| Bank of America Corp. | 0.00% | New | 100 | $126 |
| SBI Securities Co., Ltd. | 0.00% | New | 24 | $30 |
"% of holder's portfolio" is WINT's weight in each manager's 13F, not the share of Windtree Therapeutics Inc. the manager owns.